Analyze Diet

Topic:Vaccine development

Vaccine development in horses involves the creation and refinement of immunizations to protect equine populations from infectious diseases. This process includes identifying antigens, formulating vaccines, and evaluating their safety and efficacy through clinical trials. Vaccines stimulate the horse's immune system to recognize and combat specific pathogens, thereby reducing the incidence and severity of diseases. Common equine vaccines target diseases such as equine influenza, tetanus, and West Nile virus. This page compiles peer-reviewed research studies and scholarly articles that explore the methodologies, challenges, and advancements in vaccine development for equine health.
Equine influenza vaccines in Europe: a view from the animal health industry.
Equine veterinary journal    October 15, 2013   Volume 45, Issue 6 774-775 doi: 10.1111/evj.12171
Horspool LJ, King A.No abstract available
Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
Molecular immunology    October 1, 2013   Volume 57, Issue 2 66-73 doi: 10.1016/j.molimm.2013.08.009
Turki I, Hammami A, Kharmachi H, Mousli M.Human and equine rabies immunoglobulins are currently available for passive immunization against rabies. However, these are hampered by the limited supply and some drawbacks. Advances in antibody engineering have led to overcome issues of clinical applications and to improve the protective efficacy. In the present study, we report the generation of a trivalent single-chain Fv (scFv50AD1-Fd), that recognizes the rabies virus glycoprotein, genetically fused to the trimerization domain of the bacteriophage T4 fibritin, termed 'foldon' (Fd). scFv50AD1-Fd was expressed as soluble recombinant protei...
Has horsepox become extinct?
The Veterinary record    September 24, 2013   Volume 173, Issue 11 272-273 doi: 10.1136/vr.f5587
Esparza J.Mystery surrounds the extent to which horsepox virus may have contributed to the vaccinia virus used to eradicate smallpox. With few documented cases of horsepox in recent years it may never be solved, says José Esparza, who seeks to raise awareness of the potential historical and  scientific importance of identifying new cases.
Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings–a blinded comparison of commercially available vaccines.
Vaccine    September 8, 2013   Volume 31, Issue 45 5216-5222 doi: 10.1016/j.vaccine.2013.08.083
Gildea S, Quinlivan M, Murphy BA, Cullinane A.Previous studies in experimental ponies using interferon gamma (IFN-γ) as a marker for cell mediated immune (CMI) response demonstrated an increase in IFN-γ gene expression following vaccination with an ISCOM subunit, a canarypox recombinant and more recently, an inactivated whole virus vaccine. The objective of this study was to carry out an independent comparison of both humoral antibody and CMI responses elicited following vaccination with all these vaccine presentation systems. Antibody response of 44 Thoroughbred weanlings was monitored for three weeks following the second dose of prima...
Global distribution of group A rotavirus strains in horses: a systematic review.
Vaccine    August 28, 2013   Volume 31, Issue 48 5627-5633 doi: 10.1016/j.vaccine.2013.08.045
Papp H, Matthijnssens J, Martella V, Ciarlet M, Bányai K.Group A rotavirus (RVA) is a major cause of diarrhea and diarrhea-related mortality in foals in parts of the world. In addition to careful horse farm management, vaccination is the only known alternative to reduce the RVA associated disease burden on horse farms. The precise evaluation of vaccine effectiveness against circulating strains needs enhanced surveillance of equine RVAs in areas where vaccine is already available or vaccine introduction is anticipated. Therefore, we undertook the overview of relevant information on epidemiology of equine RVA strains through systematic search of publi...
Response of Australian veterinarians to the announcement of a Hendra virus vaccine becoming available.
Australian veterinary journal    July 31, 2013   Volume 91, Issue 8 328-331 doi: 10.1111/avj.12092
Mendez D, Büttner P, Speare R.A cross-sectional study of private veterinarians providing equine services in Queensland. Results: The study revealed that a majority of veterinarians would support the introduction of a Hendra virus (HeV) vaccine. Moreover, almost half of the respondents intended to make vaccination a prerequisite to horse patient presentation. However, participants also responded that a vaccine would not reduce the risk sufficiently to cease or downgrade their HeV management plan and infection control measures. Conclusions: When devising promoting and marketing campaigns, government agencies and manufacturer...
Pathogenesis of Venezuelan equine encephalitis.
Veterinary microbiology    July 22, 2013   Volume 167, Issue 1-2 145-150 doi: 10.1016/j.vetmic.2013.07.012
Taylor KG, Paessler S.Equine encephalids have high mortality rates and represent a significant zoonotic public health threat. Of these the most pathogenic viruses to equids are the alphaviruses in the family Togaviridae. The focus of this review Venezualen equine encephalitis virus (VEEV) has caused the most widespread and recent epidemic outbreaks of disease. Circulation in naturally occuring rodent-mosquito cycles, results in viral spread to both human and equine populations. However, equines develop a high titer viremia and can transmit the virus back to mosquito populations. As such, the early recognition and c...
Equine rotaviruses–current understanding and continuing challenges.
Veterinary microbiology    July 22, 2013   Volume 167, Issue 1-2 135-144 doi: 10.1016/j.vetmic.2013.07.010
Bailey KE, Gilkerson JR, Browning GF.Equine rotaviruses were first detected in foals over 30 years ago and remain a major cause of infectious diarrhoea in foals. During this time, there has been substantial progress in the development of sensitive methods to detect rotaviruses in foals, enabling surveillance of the genotypes present in various horse populations. However, there has been limited epidemiological investigation into the significance of these circulating genotypes, their correlation with disease and the use of vaccination in these animal populations. Our knowledge of the pathogenesis of rotavirus infection in foals is ...
Recovery of African horse sickness virus from synthetic RNA.
The Journal of general virology    July 16, 2013   Volume 94, Issue Pt 10 2259-2265 doi: 10.1099/vir.0.055905-0
Kaname Y, Celma CCP, Kanai Y, Roy P.African horse sickness virus (AHSV) is an insect-vectored emerging pathogen of equine species. AHSV (nine serotypes) is a member of the genus Orbivirus, with a morphology and coding strategy similar to that of the type member, bluetongue virus. However, these viruses are distinct at the genetic level, in the proteins they encode and in their pathobiology. AHSV infection of horses is highly virulent with a mortality rate of up to 90 %. AHSV is transmitted by Culicoides, a common European insect, and has the potential to emerge in Europe from endemic countries of Africa. As a result, a safe an...
Identification of novel immunoreactive proteins of Streptococcus zooepidemicus with potential as vaccine components.
Vaccine    July 8, 2013   Volume 31, Issue 38 4129-4135 doi: 10.1016/j.vaccine.2013.06.100
Velineni S, Timoney JF.Streptococcus zooepidemicus is an important opportunistic pathogen of the equine respiratory and reproductive tracts. A normal tonsillar and mucosal commensal, it becomes invasive under conditions of stress such as virus infection, weaning, high temperature, prolonged transportation and failure of uterine involution. The aim of this study was to evaluate the vaccine potential of several surface exposed and secreted proteins of a novel mucoid clone of SzNC78 (ST-307) from an epizootic of equine respiratory disease. Methods: An expression gene library of SzNC78 was probed with a pool of convales...
Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)–masters of co-evolution and a constant threat to equids and beyond.
Veterinary microbiology    July 6, 2013   Volume 167, Issue 1-2 123-134 doi: 10.1016/j.vetmic.2013.06.018
Ma G, Azab W, Osterrieder N.The equine herpesviruses type 1 (EHV-1) and 4 (EHV-4) are ubiquitous pathogens that affect horse populations on all continents. Despite widespread vaccination, EHV-1 and EHV-4 infections remain a permanent risk. While the two viruses share a high degree of genetic and antigenic similarity, they differ significantly in host range and pathogenicity. Compared to EHV-4, which mainly infects horses and causes respiratory disease, EHV-1 has a broader host range and can result in respiratory disease, abortions, neonatal death, and equine herpesvirusmyeloencephalopathy (EHM). Recent studies have eluci...
A treatment for and vaccine against the deadly Hendra and Nipah viruses.
Antiviral research    July 6, 2013   Volume 100, Issue 1 8-13 doi: 10.1016/j.antiviral.2013.06.012
Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF.Hendra virus and Nipah virus are bat-borne paramyxoviruses that are the prototypic members of the genus Henipavirus. The henipaviruses emerged in the 1990s, spilling over from their natural bat hosts and causing serious disease outbreaks in humans and livestock. Hendra virus emerged in Australia and since 1994 there have been 7 human infections with 4 case fatalities. Nipah virus first appeared in Malaysia and subsequent outbreaks have occurred in Bangladesh and India. In total, there have been an estimated 582 human cases of Nipah virus and of these, 54% were fatal. Their broad species tropis...
Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy.
Vaccine    July 2, 2013   Volume 31, Issue 51 6043-6045 doi: 10.1016/j.vaccine.2013.06.070
Daly JM, Elton D.The calculation of p(epitope) values, a sequence-based measure of antigenic distance between strains, was developed for human influenza. The potential to apply the p(epitope) value to equine influenza vaccine strain selection was assessed. There was a negative correlation between p(epitope) value and vaccine efficacy for pairs of vaccine and challenge strains used in cross-protection studies in ponies that just reached statistical significance (p=0.046) only if one pair of viruses was excluded from the analysis. Thus the p(epitope) value has potential to provide additional data to consider in ...
Envelope determinants of equine lentiviral vaccine protection.
PloS one    June 13, 2013   Volume 8, Issue 6 e66093 doi: 10.1371/journal.pone.0066093
Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC.Lentiviral envelope (Env) antigenic variation and associated immune evasion present major obstacles to vaccine development. The concept that Env is a critical determinant for vaccine efficacy is well accepted, however defined correlates of protection associated with Env variation have yet to be determined. We reported an attenuated equine infectious anemia virus (EIAV) vaccine study that directly examined the effect of lentiviral Env sequence variation on vaccine efficacy. The study identified a significant, inverse, linear correlation between vaccine efficacy and increasing divergence of the ...
Characterization and protective immunogenicity of the SzM protein of Streptococcus zooepidemicus NC78 from a clonal outbreak of equine respiratory disease.
Clinical and vaccine immunology : CVI    June 5, 2013   Volume 20, Issue 8 1181-1188 doi: 10.1128/CVI.00069-13
Velineni S, Timoney JF.Streptococcus zooepidemicus of Lancefield group C is a highly variable tonsillar and mucosal commensal that usually is associated with opportunistic infections of the respiratory tract of vertebrate hosts. More-virulent clones have caused epizootics of severe respiratory disease in dogs and horses. The virulence factors of these strains are poorly understood. The antiphagocytic protein SeM is a major virulence factor and protective antigen of Streptococcus equi, a clonal biovar of an ancestral S. zooepidemicus strain. Although the genome of S. zooepidemicus strain H70, an equine isolate, conta...
Development of a focus-reduction neutralizing test for detecting equine herpesvirus type-1-neutralizing antibodies.
The Journal of veterinary medical science    April 16, 2013   Volume 75, Issue 9 1209-1212 doi: 10.1292/jvms.13-0043
Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kondo T, Matsumura T.Virus-neutralizing (VN) testing is essential for evaluating virus-specific immunity in equine herpesvirus type-1 (EHV-1) infection. We developed a focus-reduction neutralization test (FRNT) for EHV-1 using 96-well plates for faster large-scale testing with sufficient sensitivity. We used an overlay medium containing Avicel (FMC Biopolymer), a microcrystalline cellulose with lower viscosity than the methylcellulose. The foci were visualized by immuno-staining with anti-EHV-1 gp14 monoclonal antibody. The FRNT successfully detected seroconversion in horses experimentally infected with EHV-1 (n =...
Strangles: taking steps towards eradication.
Veterinary microbiology    April 12, 2013   Volume 167, Issue 1-2 50-60 doi: 10.1016/j.vetmic.2013.03.033
Waller AS.Strangles, caused by the host adapted Lancefield group C bacterium Streptococcus equi sub-species equi (S. equi), is one of the oldest recognised infectious diseases of horses and continues to cause significant welfare and economic cost throughout the world. The ability of S. equi to establish sub-clinical persistent infections primarily in the guttural pouches of convalescent horses has been instrumental to its success. However, the implementation of simple control measures that permit the identification and treatment of persistently infected carriers can prevent further outbreaks of disease ...
Replication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferrets.
Journal of virology    April 10, 2013   Volume 87, Issue 12 6901-6910 doi: 10.1128/JVI.03520-12
Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Jin H, Subbarao K.Since it is difficult to predict which influenza virus subtype will cause an influenza pandemic, it is important to prepare influenza virus vaccines against different subtypes and evaluate the safety and immunogenicity of candidate vaccines in preclinical and clinical studies prior to a pandemic. In addition to infecting humans, H3 influenza viruses commonly infect pigs, horses, and avian species. We selected 11 swine, equine, and avian H3 influenza viruses and evaluated their kinetics of replication and ability to induce a broadly cross-reactive antibody response in mice and ferrets. The swin...
Equine influenza–a global perspective.
Veterinary microbiology    April 9, 2013   Volume 167, Issue 1-2 205-214 doi: 10.1016/j.vetmic.2013.03.029
Cullinane A, Newton JR.To date, equine influenza outbreaks have been reported all over the world with the exception of a small number of island nations including New Zealand and Iceland. Influenza is endemic in Europe and North America and is considered to be of potentially major economic significance to the equine industry worldwide. The importation of subclinically infected vaccinated horses, and inadequate quarantine procedures have resulted in several major outbreaks in susceptible populations for example, in Australia (2007) when more than 76,000 horses on over 10,000 properties were reported as infected. This ...
Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Veterinaria italiana    April 9, 2013   Volume 49, Issue 1 89-98 
Lelli R, Molini U, Ronchi GF, Rossi E, Franchi P, Ulisse S, Armillotta G, Capista S, Khaiseb S, Di Ventura M, Pini A.African horse sickness (AHS) is a non-contagious viral disease of solipeds transmitted by Culicoides. The disease is endemic in most African countries. Past experience has shown that Italy is a country exposed to emerging infectious diseases endemic to Africa; an incursion of AHS virus together with the widespread presence of Culicoides vectors could be the cause of a serious epidemic emergency. A live attenuated vaccine containing seven of the nine viral serotypes, serotype 5 and 9 are excluded, is commercially available from Onderstepoort Biological Products. However, the use of live vaccine...
Repertoire of Theileria equi immunodominant antigens bound by equine antibody.
Molecular and biochemical parasitology    March 26, 2013   Volume 188, Issue 2 109-115 doi: 10.1016/j.molbiopara.2013.03.002
Silva MG, Graça T, Suarez CE, Knowles DP.Theileriosis in horses and cattle is caused by tick-borne Apicomplexa parasites and results in death or life-long infection in their respective hosts. Transmission risk associated with persistent infection severely limits movement of horses and cattle resulting in economic losses. The recent reemergence of Theileria equi infection in U.S. horses demonstrates the continual threat Apicomplexa parasites represent to global animal health. A paucity of data concerning equine immune responses to T. equi, including antigens recognized by antibodies in clinically asymptomatic, persistently infected ho...
Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.
Journal of virology    March 6, 2013   Volume 87, Issue 10 5447-5460 doi: 10.1128/JVI.03462-12
Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Owens G, Custer M, Kamrud K, de los Santos T, Grubman MJ.We have previously shown that delivery of the porcine type I interferon gene (poIFN-α/β) with a replication-defective human adenovirus vector (adenovirus 5 [Ad5]) can sterilely protect swine challenged with foot-and-mouth disease virus (FMDV) 1 day later. However, the need of relatively high doses of Ad5 limits the applicability of such a control strategy in the livestock industry. Venezuelan equine encephalitis virus (VEE) empty replicon particles (VRPs) can induce rapid protection of mice against either homologous or, in some cases, heterologous virus challenge. As an alternative approach ...
Eliminating infectious diseases of livestock: a metapopulation model of infection control.
Theoretical population biology    March 4, 2013   Volume 85 63-72 doi: 10.1016/j.tpb.2013.02.002
Glass K, Barnes B.When novel disease outbreaks occur in livestock, policy makers must respond promptly to eliminate disease, and are typically called on to make control decisions before detailed analysis of disease parameters can be undertaken. We present a flexible metapopulation model of disease spread that incorporates variation in livestock density and includes occasional high-mixing locations or events, such as markets or race meetings. Using probability generating functions derived from this branching process model, we compare the likely success of reactive control strategies in eliminating disease spread...
Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.
Proceedings of the National Academy of Sciences of the United States of America    February 11, 2013   Volume 110, Issue 9 E838-E847 doi: 10.1073/pnas.1218464110
van Kasteren PB, Bailey-Elkin BA, James TW, Ninaber DK, Beugeling C, Khajehpour M, Snijder EJ, Mark BL, Kikkert M.Protein ubiquitination regulates important innate immune responses. The discovery of viruses encoding deubiquitinating enzymes (DUBs) suggests they remove ubiquitin to evade ubiquitin-dependent antiviral responses; however, this has never been conclusively demonstrated in virus-infected cells. Arteriviruses are economically important positive-stranded RNA viruses that encode an ovarian tumor (OTU) domain DUB known as papain-like protease 2 (PLP2). This enzyme is essential for arterivirus replication by cleaving a site within the viral replicase polyproteins and also removes ubiquitin from cell...
Identification of a major immunogenic region of equine herpesvirus-1 glycoprotein E and its application to enzyme-linked immunosorbent assay.
Veterinary microbiology    February 4, 2013   Volume 164, Issue 1-2 18-26 doi: 10.1016/j.vetmic.2013.01.033
Andoh K, Takasugi M, Mahmoud HY, Hattori S, Terada Y, Noguchi K, Shimoda H, Bannai H, Tsujimura K, Matsumura T, Kondo T, Maeda K.A major immunogenic region of equine herpesvirus (EHV)-1 glycoprotein E (gE) was identified. Firstly, the various fragments of EHV-1 gE were expressed as fusion proteins with glutathione S-transferase (GST) in Escherichia coli and their antigenicities were compared by immunoblot analysis using sera from horses experimentally infected with EHV-1. Thirty-three amino acids of gE (a.a. 169-201) specifically and sensitively reacted with the antibodies induced by EHV-1 but not EHV-4 infection. The corresponding region of EHV-4 gE (a.a. 169-199) did not react with antibodies to EHV-1, indicating that...
IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
Virology    January 22, 2013   Volume 437, Issue 2 81-88 doi: 10.1016/j.virol.2012.11.013
Rossi SL, Guerbois M, Gorchakov R, Plante KS, Forrester NL, Weaver SC.Venezuelan equine encephalitis virus (VEEV) is an arbovirus that causes periodic outbreaks that impact equine and human populations in the Americas. One of the VEEV subtypes located in Mexico and Central America (IE) has recently been recognized as an important cause of equine disease and death, and human exposure also appears to be widespread. Here, we describe the use of an Internal Ribosome Entry Site (IRES) from encephalomyocarditis virus to stably attenuate VEEV, creating a vaccine candidate independent of unstable point mutations. Mice infected with this virus produced antibodies and wer...
Outbreaks of African horse sickness in Senegal, and methods of control of the 2007 epidemic.
The Veterinary record    December 7, 2012   Volume 172, Issue 6 152 doi: 10.1136/vr.101083
Diouf ND, Etter E, Lo MM, Lo M, Akakpo AJ.Since first being detected in Nigeria in January 2007, African horse sickness virus serotype 2 (AHSV-2) has spread throughout the northern hemisphere, and was first reported in Senegal. A retrospective study was conducted from December 2009 to April 2010 using data collected in the field combined with information available at the Direction of Veterinary Services. The epidemic started in the Dakar region with two outbreaks in March and June 2007, respectively, and spread in several parts of the country between July and November 2007. During this period, 232 outbreaks and 1137 horse deaths were ...
Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine production.
Journal of biotechnology    November 29, 2012   Volume 167, Issue 2 135-141 doi: 10.1016/j.jbiotec.2012.11.003
Soares SC, Trost E, Ramos RT, Carneiro AR, Santos AR, Pinto AC, Barbosa E, Aburjaile F, Ali A, Diniz CA, Hassan SS, Fiaux K, Guimarães LC....Corynebacterium pseudotuberculosis is the causative agent of several veterinary diseases in a broad range of economically important hosts, which can vary from caseous lymphadenitis in sheep and goats (biovar ovis) to ulcerative lymphangitis in cattle and horses (biovar equi). Existing vaccines against C. pseudotuberculosis are mainly intended for small ruminants and, even in these hosts, they still present remarkable limitations. In this study, we present the complete genome sequence of C. pseudotuberculosis biovar equi strain 258, isolated from a horse with ulcerative lymphangitis. The genome...
A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.
Viral immunology    November 21, 2012   Volume 25, Issue 6 477-484 doi: 10.1089/vim.2012.0014
Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Yang K, Zhou J, Shen R, Zhang X, Shao Y.Data from successful attenuated lentiviral vaccine studies indicate that fully mature Env-specific antibodies characterized by high titer, high avidity, and the predominant recognition of conformational epitopes are associated with protective efficacy. Although vaccination with a DNA prime/recombinant vaccinia-vectored vaccine boost strategy has been found to be effective in some trials with non-human primate/simian/human immunodeficiency virus (SHIV) models, it remains unclear whether this vaccination strategy could elicit mature equine infectious anemia virus (EIAV) Env-specific antibodies, ...
History of Orbivirus research in South Africa.
Journal of the South African Veterinary Association    November 13, 2012   Volume 83, Issue 1 532 doi: 10.4102/jsava.v83i1.532
Verwoerd DW.In the early colonial history of South Africa, horses played an important role, both in general transportation and in military operations. Frequent epidemics of African horsesickness (AHS) in the 18th century therefore severely affected the economy. The first scientific research on the disease was carried out by Alexander Edington (1892), the first government bacteriologist of the Cape Colony, who resolved the existing confusion that reigned and established its identity as a separate disease. Bluetongue (BT) was described for the first time by Duncan Hutcheon in 1880, although it was probably ...
1 11 12 13 14 15 34